Author

Calogero Camma

REMOTE MONITORING IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS FROM A SURVEY PERFORMED DURING COVID-19 OUTBREAK
REMOTE MONITORING IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS FROM A SURVEY PERFORMED DURING COVID-19 OUTBREAK

Calogero Camma  et al.

TELEMEDICINE IS AN EFFECTIVE TOOL TO MONITOR DISEASE ACTIVITY IN IBD PATIENTS IN THE COVID-19 ERA: A SINGLE CENTRE EXPERIENCE BASED ON OBJECTIVE DATA
TELEMEDICINE IS AN EFFECTIVE TOOL TO MONITOR DISEASE ACTIVITY IN IBD PATIENTS IN THE COVID-19 ERA: A SINGLE CENTRE EXPERIENCE BASED ON OBJECTIVE DATA

Calogero Camma  et al.

AN INDIRECT COMPARISON OF ADALIMUMAB AND AZATHIOPRINE IN THE MANAGEMENT OF STEROID DEPENDENT INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER REAL WORLD STUDY
AN INDIRECT COMPARISON OF ADALIMUMAB AND AZATHIOPRINE IN THE MANAGEMENT OF STEROID DEPENDENT INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER REAL WORLD STUDY

Calogero Camma  et al.

TELEMEDICINE IN THE MANAGEMENT OF IBD PATIENTS: A SAFE AND FEASIBILE APPROACH WITH DEDICATED TOOLS
TELEMEDICINE IN THE MANAGEMENT OF IBD PATIENTS: A SAFE AND FEASIBILE APPROACH WITH DEDICATED TOOLS

Calogero Camma  et al.

COMPARATIVE EFFICACY OF SECOND-LINE THERAPIES IN ULCERATIVE COLITIS: A MONOCENTRIC EXPERIENCE FROM A TERTIARY REFERRAL CENTER
COMPARATIVE EFFICACY OF SECOND-LINE THERAPIES IN ULCERATIVE COLITIS: A MONOCENTRIC EXPERIENCE FROM A TERTIARY REFERRAL CENTER

Calogero Camma  et al.

OPTIMIZING SEQUENTIAL SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELULLAR CARCINOMA: A DECISION ANALYSIS
OPTIMIZING SEQUENTIAL SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELULLAR CARCINOMA: A DECISION ANALYSIS

Calogero Camma  et al.

PROGRESSION-FREE SURVIVAL IS A CONSISTENT SURROGATE ENDPOINT OF OVERALL SURVIVAL IN IMMUNOTHERAPY TRIALS OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS
PROGRESSION-FREE SURVIVAL IS A CONSISTENT SURROGATE ENDPOINT OF OVERALL SURVIVAL IN IMMUNOTHERAPY TRIALS OF ADVANCED HEPATOCELLULAR CARCINOMA: A META-ANALYSIS

Calogero Camma  et al.

Item 1 - 7 / 7
1